While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...
An FDA officer explains the agency’s compliance requirements for importing pharmaceuticals and biologics and processes.
AstraZeneca has announced a $2bn investment plan to expand its biomanufacturing presence in Frederick, Maryland, US.
Lilly breaking through the $1tn market cap ceiling comes as investors have increasingly turned to pharma stocks. The S&P 500 ...
OSR Company Vaximm has linked with investor BCM Europe (BCME) for a potential exclusive worldwide licence for Vaximm’s VXM01.
The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in ...
In 2024, the FDA granted a record 63 designations to antibody drug conjugates (ADCs), nearly double the previous high of 35 ...
Advances in large-volume injectors are enabling faster, more comfortable, at-home treatment. Patient-centric design, ...
When a drug product is unstable—whether it is sensitive to light, shear, or temperature—the formulation and sterile filling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback